Creso Pharma Limited

ASX (AUD): Creso Pharma Limited (CPH)

Last Price

0.01

Today's Change

0.00 (0.00%)

Day's Change

0.01 - 0.011

Trading Volume

2,598,638

Profile
CPH

Exchange: 

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO: 

Full Time Employees: 

IPO Date: 

CIK: 

ISIN: 

CUSIP: 

Beta: 

Last Dividend: 

Dcf Diff: 

Dcf: 

Description

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Address
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment